Overview
- 32 inspections across 30 sites are on record.
- 149 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-01-29.
At a glance
Inspections
32
Sites
30
Observations
149
Career since
Mar 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Berlimed SA | 29 Jan 2016 | Human Drugs | View 483 → |
| IFTS | 18 Jan 2016 | Human Drugs | View 483 → |
| Keybio | 13 Jan 2016 | Human Drugs | View 483 → |
| Central Admixture Pharmacy Services, Inc. | 4 Dec 2015 | Human Drugs | View 483 → |
| Par Health USA, LLC | 28 Sep 2015 | Human Drugs |
Sites inspected
Berlimed SAAlcala de Henares, Spain1 insp.
IFTSFoulayronnes, France1 insp.
KeybioAubagne, France1 insp.
Central Admixture Pharmacy Services, Inc.Livonia, United States1 insp.
Par Health USA, LLCRochester, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sarah M Napier8 shared
Emily J Orban7 shared
Jeffrey D Meng4 shared
Cynthia A Palmer3 shared
Cheng H Yen2 shared
Carmen M Faraianu2 shared
Rebecca E Dombrowski2 shared
Andrew J Idzior2 shared
Wendy M Stark1 shared
Martin R Vowell1 shared
Full investigator report
Get the verbatim findings behind Sarah M Meng's 149 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site